Medical Data Vision (MDV)

What Medical Data Vision (MDV) does

Medical Data Vision Co., Ltd. (MDV) is a Japanese healthcare data company founded in 2003 and headquartered in Chiyoda, Tokyo. The company operates the MDV Database, one of the largest medical databases in Japan, built by collecting and treating administrative data from over 850 hospitals and covering treatment and condition records on more than 60 million patients. MDV monetizes this dataset by providing pharmaceutical companies, medical device manufacturers, and research institutions with access to anonymized real-world data that supports analysis of medication decision-making, treatment patterns, and patient outcomes.

The company's core technology is the proprietary MDV Database and its associated productized analytics offering, MDV RWD Insight. The platform ingests hospital administrative claims and treatment records, normalizes them, and exposes them for real-world evidence (RWE) studies. Customer segments are organized vertically across pharmaceutical companies, medical device manufacturers, and research institutions, with the English-language corporate website signaling intent to serve international buyers seeking Japan-specific real-world data. Pricing is not publicly disclosed and the go-to-market is enterprise direct sales initiated through the company website.

MDV's business model is data monetization — licensing access to its aggregated, anonymized clinical dataset to enterprise buyers who use it for evidence generation, commercial analytics, and research. The company maintains a formalized Investor Relations function covering corporate governance, sustainability, integrated reporting, and shareholder meetings, suggesting public-market or public-market-equivalent disclosure standards. As of the available data, MDV reports serving over 100 companies. Strategic moves disclosed include continued database scaling, the productization of MDV RWD Insight, English-language market outreach, and the build-out of IR and governance infrastructure. No funding rounds, acquisitions, partnerships, or leadership changes are disclosed in the input data.

Name

Medical Data Vision (MDV)

Legal name

Medical Data Vision Co., Ltd.

Website

https://en.mdv.co.jp

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Medical Data Vision operates one of Japan's largest medical databases, built from administrative data of 850+ hospitals covering 60+ million patients, and sells real-world data access to pharmaceutical companies, medical device manufacturers, and research institutions for treatment and medication decision-making analysis.

Ownership category

akta.pro rank

Product category

Healthcare Data Analytics

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)

akta.pro primary industry

Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB)

Keywords

• Medical data analytics
• Real-world evidence
• Healthcare database services
• Administrative claims data
• Pharmaceutical data insights

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Infrastructure

Revenue model

1. Medical Data Services: Providing pharmaceutical companies, medical device manufacturers, and research institutions with access to anonymized medical data to understand decision-making processes for medication in view of diseases under treatment

Distribution channels1 record

Marketing channels1 record

Core offering

Medical Data Vision (MDV) operates a large-scale Japanese medical database, the MDV Database, built by collecting and treating administrative data from over 850 hospitals covering more than 60 million patients. The company sells access to this anonymized real-world data and related analytics services to pharmaceutical companies, medical device manufacturers, and research institutions to support understanding of treatment patterns, medication decision-making, and disease outcomes.

Product overview

Medical Data Vision (MDV) offers a unified data platform centered on its MDV Database, which aggregates administrative medical data from over 850 Japanese hospitals covering 60 million patients. The core database product enables analysis of medication decision-making and treatment patterns. MDV RWD Insight serves as a product offering for real-world data analysis targeted at pharmaceutical companies, medical device manufacturers, and research institutions. The company was established in 2003 and serves over 100 companies.

Differentiator

Problem solved

Functional benefit

Brands

• MDV RWD insight: A product/service providing real-world data insights from the MDV database for pharmaceutical companies, medical device manufacturers, and research institutions.

Products and services

• MDV Database A large-scale Japanese medical database built by collecting and treating administrative data from over 850 hospitals, providing insight on the treatment and condition of over 60 million patients, used to understand the medication decision-making process for diseases under treatment.
• MDV RWD Insight A product offering for analyzing real-world data (RWD) drawn from the MDV Database, targeted at pharmaceutical companies, medical device manufacturers, and research institutions to support evidence-based decision making in healthcare and medical research.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• TriNetX: TriNetX operates a global federated real-world data network used by pharma for clinical trial feasibility and real-world evidence studies. Its data-on-demand model for life sciences customers is highly comparable to MDV's pharma/ device value proposition.
• Syapse: Syapse operates a real-world evidence platform combining clinical, molecular, and outcomes data for oncology and other therapeutic areas, sold to pharma and providers. It is a direct RWD-to-pharma peer in business model even though primarily US-based.
• JMDC Inc. JMDC operates one of Japan's largest health insurance claims databases and sells anonymized RWD to pharma, academia, and government. Like MDV, JMDC monetizes Japanese real-world medical data for decision-making; the two are the closest domestic competitors in this space.
• DeSC Healthcare Inc. DeSC Healthcare builds personal health records and operates a healthcare data platform in Japan, monetizing anonymized data for research and pharma customers. It competes head-to-head with MDV for Japanese real-world data buyers and hospital/ insurer partnerships.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving hospitals, health systems, and life sciences companies with aggregated clinical and claims data. It mirrors MDV's model of monetizing healthcare data assets for operational and research insights.

Broad incumbents

• Oracle Health (formerly Cerner): Oracle Health aggregates large-scale EHR data through Cerner's installed hospital base and offers life sciences analytics including real-world data products. It is comparable as a hospital-data-driven RWD vendor, though as part of a broader EHR portfolio.
• IQVIA Holdings: IQVIA is the global leader in real-world evidence and healthcare data, offering claims, EHR, and proprietary datasets to pharma and medtech customers. It overlaps MDV's value proposition for pharma RWD buyers at far greater scale and geographic reach.
• Veradigm (formerly Allscripts): Veradigm provides EHR systems to US providers and monetizes de-identified clinical data via its Veradigm Network for research and life sciences customers. It is comparable to MDV as a hospital-data RWD provider, though US-focused and broader in scope.
• Optum (UnitedHealth Group): Optum owns one of the largest US healthcare data assets (claims + EHR + pharmacy) and serves life sciences R&D customers with RWD and analytics. It competes with MDV at the pharma-buyer level even though its footprint is US-centric.

Regional players

• Flatiron Health: Flatiron Health aggregates oncology EHR data in the US and sells real-world evidence to pharma and regulators (now part of Roche). It is comparable to MDV in RWD-for-pharma business model but focuses on US oncology rather than Japan broadly.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medical-data-vision-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Data Vision (MDV)